APA (7th ed.) Citation

VGH, L., & JSJ, L. (2025). Trastuzumab-deruxtecan in breast cancer treatment: Balancing the triad of efficacy, safety and accessibility. Annals of the Academy of Medicine, Singapore, 54(8), 455. https://doi.org/10.47102/annals-acadmedsg.2025229

Chicago Style (17th ed.) Citation

VGH, Lee, and Lim JSJ. "Trastuzumab-deruxtecan in Breast Cancer Treatment: Balancing the Triad of Efficacy, Safety and Accessibility." Annals of the Academy of Medicine, Singapore 54, no. 8 (2025): 455. https://doi.org/10.47102/annals-acadmedsg.2025229.

MLA (9th ed.) Citation

VGH, Lee, and Lim JSJ. "Trastuzumab-deruxtecan in Breast Cancer Treatment: Balancing the Triad of Efficacy, Safety and Accessibility." Annals of the Academy of Medicine, Singapore, vol. 54, no. 8, 2025, p. 455, https://doi.org/10.47102/annals-acadmedsg.2025229.